| Status | Study |
| Not yet recruiting |
Study Name: Miltefosine and GM-CSF in Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2016-12-27 Interventions: Drug: Sbv Standard treatment f |
| Completed |
Study Name: Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis Condition: Cutaneous Leishmaniasis. Date: 2016-03-04 Interventions: Drug: Single dose of Pentacarinat® |
| Completed |
Study Name: WR 279,396 for the Treatment of Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2013-11-14 Interventions: Drug: WR 279,396 Paromomycin + Gentamicin Topical Cream |
| Completed |
Study Name: Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia Condition: Cutaneous Leishmaniasis Date: 2013-04-24 Interventions: Drug: Topical Amphotericin B at 3% Other Name: Anfoleish |
| Completed |
Study Name: Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama Condition: Cutaneous Leishmaniasis Date: 2013-02-05 Interventions: Drug: WR 279,396 WR 279,396 is |
| Available |
Study Name: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis Condition: Leishmaniasis, Cutaneous Date: 2012-06-18 Interventions: Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days |
| Completed |
Study Name: Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2011-10-24 Interventions: Drug: Meglumine antimonate Glu |
| Completed |
Study Name: Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2011-06-23 Interventions: Drug: Pentoxifylline Patients |
| Active, not recruiting |
Study Name: Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis Condition: Cutaneous Leishmaniasis Date: 2011-02-20 Interventions: Drug: Meglumine antimoniate Meglumine antimoniate is store |
| Terminated |
Study Name: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis Condition: Leishmaniasis, Cutaneous Date: 2010-06-07 Interventions: Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f |